Mkpebi Cochrane na AI: Ịkwado ihe akaebe Peptide n'enweghị nsogbu

Nkwenye ngwa ngwa nke ụdị asụsụ buru ibu (Ndị LLM) na ọgụgụ isi na-emepụta ihe agbanweela ngwuputa akwụkwọ biomedical. Ndị otu nyocha gafere mmalite biotechnology, ụlọ ọrụ ọgwụ, na ụlọ ọrụ nyocha nkwekọrịta (CROs) na-ebuga ndị ọrụ akpaaka ka ha chịkọta akwụkwọ, wepụ data nyocha, ma mee ngwa ngwa njikarịcha ndu. Agbanyeghị, na nyocha usoro na nchịkọta ihe akaebe, Edepụtala ahịrị usoro dị mkpa n'ájá.

Na ntọhapụ dị ịrịba ama, nke Nkwupụta ọnọdụ nkwonkwo Cochrane na AI nwere ọrụ na njikọ ihe akaebe-Ebipụtara ya na mmekorita Campbell, JBI, na mmekorita maka ihe akaebe gburugburu ebe obibi - guzosiri ike na AI kwụ ọtọ enweghị ike ije ozi dị ka onye na-emepụta ihe akaebe kwụụrụ onwe ya.. Na-arụ ọrụ n'okpuru ọrụ nke AI na-egosi SynthEsis (bulie) kpuchie, mkpebi ahụ enweghị mgbagwoju anya: ebe ngwaọrụ AI nwere ike inye aka na nhazi ajụjụ mbido na mmịpụta nhazi, Agụmakwụkwọ sayensị na usoro iwu ka bụ nke mmadụ. Ụdị ndị na-emepụta ihe agaghị eme mkpebi nlebara anya na-enweghị akwụkwọ, nlekota oru mmadu.

Maka ndị ọkà mmụta sayensị biopharma na ihe akaebe na-eduga na-arụ ọrụ na ọgwụgwọ peptide, antibody-ọgwụ conjugates (ADC), na peptide-ọgwụ conjugates (Ndị PDC), mkpebi a abụghị ihe mgbochi mgbochi. Kama, ọ na-enye ụkpụrụ dị mkpa maka nlanarị. Sayensị peptide na-ewepụta ụdị nyocha pụrụ iche na ọdịda kemịkalụ na nhazi asụsụ eke (NLP) ụdị na- fundamentally adịghị njikere aka. Ịtụkwasị obi na mmịpụta AI enyochabeghị maka nrụpụta ihe akaebe peptide na-emepụta ihe egwu nchịkwa siri ike, Ọdịdị ụgha-mmekọrịta ọrụ (SAR) akara, na oké ọnụ ụlọ ọgwụ ọdịda.

Edemede a na-enyocha ihe kpatara ụdị AI izugbe na-ada ada mgbe ị na-ahazi data peptide, na-akọwapụta usoro ngwakọ mmadụ-gbakwunyere-AI na-egosi usoro nhazi ọrụ, na-akọwapụta atụmatụ metadata amanyere iwu chọrọ maka ntunyere nza, ma na-enye usoro nyocha ihe ndekọ ọnụ ọgụgụ iji hụ na ihe akaebe agbakwunyere na-akwado nyocha nke FDA na IND siri ike..

Ihe kpatara General AI ji ada na sayensị Peptide: Ebe Bioanalytical Blind Spots

General LLMs na-arụ ọrụ na amụma amụma ndekọ aha kama ịghọta ngalaba kemịkal. Mgbe ị na-ewepụta data nnwale sitere na akwụkwọ ndị e bipụtara, patent, ma ọ bụ akụkọ ime, Ndị nyocha AI izugbe na-agbagwoju anya mkpesa elu yana ezigbo nha anya nyocha. N'ịchọpụta ihe akaebe peptide, ntụpọ anọ bụ isi bioanalytical kpuru na-emebi mmịpụta akpaghị aka.

Ntugharị igodo: Ngwá ọrụ mmịpụta AI dị elu na-ejikọta ịdị ọcha nke usoro HPLC na ọdịnaya peptide net., Ọ̀tụ̀tụ̀ nnu counterion na-efu na oke nyocha na-abụghị orthogonal. Mwepụta AI enyochabeghị nwere ike iwebata 20% ka 40% mperi na nyocha ọnụọgụ ọnụọgụ ọnụọgụ meta-analyses.

1. Na-ejikọta ịdị ọcha HPLC na ọdịnaya Peptide Net (NPC)

Njehie mmịpụta data kacha gbasaa na nyocha peptide akpaaka bụ ọgwụgwọ Liquid Chromatography Liquid-Phase High Performance Liquid. (RP-HPLC) ọnụ ọgụgụ kasị elu ebe ịdị ọcha dị ka ihe mkpokọta ibu ọrụ.

Akwụkwọ na-akọ "10 mg nke peptide synthesized na 98% ịdị ọcha” enweghị 9.8 mg nke peptide na-arụ ọrụ. Lyophilized peptide powders dị dị ka nnu nwere ọnụ ọgụgụ dị iche iche nke mgbochi agbụ (A na-ahụkarị trifluoroacetate, acetate, ma ọ bụ chloride) na mmiri a na-ekekọtaghị ọnụ. Ọdịnaya peptide net (NPC) na-adịkarị n'etiti 50% na 80% nke mkpokọta oke ibu. Ihe atụ AI na-ewepụta oke oke na-agbakọghị NPC na-ewebata a 20% ka 40% nleba anya nke usoro onunu ogwu na-arụ ọrụ na nyocha meta-esochi, skewing gbakọọ IC50, EC50, na ọnụ ụzọ toxicity.

2. Mwepu nke ụdị Counterion na ihe ndị na-egbu egbu

N'oge siri ike-phase peptide njikọ (SPSS), nkwụsị ikpeazụ site na resin site na iji trifluoroacetic acid (TFA) na-ahapụ ihe mgbochi TFA fọdụrụnụ jikọtara na agbụ akụkụ amino acid bụ isi (Lys, Arg, Ya) na N-terminus. TFA fọdụrụnụ bụ acid siri ike yana ihe mgbanwe ndu na-arụ ọrụ. N'ime nyocha ike dabere na cell, Mgbanwe TFA na-agbanweghị agbanwe na-adaba pH micro-gburugburu, na-egbochi mgbasa nke cellular, na-agbanwe cell membrane permeability, na ịkpata cytotoxicity na-abụghị nke akọwapụtara.

Ọ gwụla ma ngwa ngwa ahaziri ahazi chọrọ n'ụzọ doro anya mmịpụta mgbochi, Ngwa LLM ọkọlọtọ na-eleghara anya ma ọmụmụ ejiri nnu TFA mee ihe, Nnu acetate, ma ọ bụ hydrochloride (HCl) nnu. Tụnyere ịdị irè ndu n'ofe ọmụmụ na-emezigharịghị steeti mgbochi na-ewepụta data SAR na-emegiderịta onwe ya.

3. Ìsì gaa na usoro nyocha Orthogonality

Mgbe ihe atụ AI wepụrụ “Ọcha: 95%”, ọ naghị esiri ike ịchọpụta usoro nyocha dị n'okpuru. Otu ọsọ RP-HPLC tụrụ na 220 nm na-enyocha adịghị ọcha peptide nke na-ebu UV mana ọ ka kpuru kpamkpam na steeti nchịkọta soluble (dị ka dimers ma ọ bụ oligomers) ma ọ bụ nnu na-adịghị anabata UV.

Na-enweghị nkwado orthogonal-ijikọta RP-HPLC, Chromatography nha-wepu (SEC-HPLC) maka mkpokọta profaịlụ, Mass Spectrometry (LC-MS / MALDI-TOF) maka monoisotopic mass nkwenye, na Amino Acid Analysis (AAA) maka ngụpụta zuru oke—ọnụọgụ ịdị ọcha a kọrọ na ezughị oke.

4. Mgbakọ na nhazi ụgbọ ala ambiguity

Peptides bụ ụmụ irighiri ihe na-eme ka ọ na-agbakọta onwe ya n'ime fibrils beta-sheet ma ọ bụ amorphous aggregates dabere na pH ụgbọ ala., ike ionic, ọnụnọ surfactant, na okirikiri ifriizi-hapụrụ. Ụdị NLP General na-achịkọta data bioactivity site na ọmụmụ site na iji usoro monomeric n'akụkụ ọmụmụ site na iji ngwọta nchịkọta., na-ekwu na bioactivity na-agbanwe agbanwe na usoro nke mbụ karịa ọnọdụ anụ ahụ.

Usoro ọrụ nrụpụta ngwakọ mmadụ-Plus-AI a tụrụ atụ aro

Iji kwado njikọ ihe akaebe peptide na iwu Cochrane na atụmanya nchịkwa, Ndị otu biopharma ga-emejuputa usoro ngwakọ nwere ọtụtụ agba. N'ime ihe owuwu a, AI na-ejikwa ntinye akwụkwọ dị elu yana nnabata ụlọ ọrụ, ebe ndị ọkachamara mmadụ na-arụ ọrụ dị ka ndị nche ọnụ ụzọ ámá amanyere iwu na ebe nlele ikpe akọwapụtara.

v Nyochaa nha nha oke | Usoro vs Monoisotopic Mass | Nyochaa bara uru na-agafe iwu na-ada iwu / Nnukwu ihe ize ndụ v v

OGE 1: Ntinye akpaghị aka & LLM na-enyocha ntinye ọtụtụ usoro (PDF/Patent) -> Nhazi Mwepụta Ngwa JSON Haziri 2: Mgbochi mmachi dabere n'iwu dabere na mkpebi siri ike 4: Nyocha njikwa ogo ndekọ ọnụ ọgụgụ | | OGE 3: Nlereanya Ọkachamara mmadụ n'ihe ize ndụ & Inter-Annotator Kappa | | Ebe nlele ikpe

Ogbo 1: Ntinye akpaaka na nyocha LLM

Depụta nzacha akwụkwọ na LLM ndị emeziri nke ọma na-ahazi akwụkwọ izizi, patent, na teknuzu dossier. AI na-ewepụta ederede, tebụl, na ihe mgbakwunye, na-atụgharị prose edebere ka ọ bụrụ atụmatụ JSON akọwapụtara nke ọma.

Ogbo 2: Nkwenye mmachi mkpebi siri ike

Tupu nyocha mmadụ, Igwe iwu akpaghị aka na-akwado data ewepụtara megide mgbagha siri ike biochemical:

Nyochaa nha nha oke: Arọ molekụla akọpụtara ọ dabara na usoro izizi?
Ịdị ọcha vs. Nyochaa ọdịnaya: A na-akọ na ịdị ọcha dị iche na ọdịnaya peptide net?
Nleba anya nleba anya: A na-akọ ụkpụrụ IC50 jikọtara ya na nkeji ịta ahụhụ doro anya yana ọnọdụ nchekwa?

Ọ bụrụ na mmịpụta na-emebi ihe mgbochi biochemical bụ isi, sistemụ na-akpaghị aka na-edekọ ndekọ maka ikpe mmadụ kacha mkpa.

Ogbo 3: Ebe ndị ọkachamara n'ihe gbasara mmadụ

Ikpe mmadụ bụ iwu na ebe nyocha sayensị anọ akọwapụtara tupu ebe data ọ bụla abanye na ebe nchekwa njikọ etiti.:

⚠️ Ịdọ aka ná ntị dị mkpa: Agafela mmịpụta AI na-akwadoghị n'ime akwụkwọ IND ma ọ bụ NDA na-achịkwa. Mwepụta akpaghị aka na-enweghị nkwado mmadụ na ebe nyocha nyocha dị oke egwu na-emebi usoro Cochrane yana ihe egwu na-ajụ usoro iwu n'oge nyocha ụlọ ọrụ..

Ebe nyocha ikpe A: Ụdị nnu na nkwenye mgbochi

Ndị ọkachamara mmadụ na-enyocha ihe ndekọ niile ebe counterion na-akọwaghị ma ọ bụ ebe TFA-to-acetate counterion mgbanwe ọnọdụ bụ ihe mgbagwoju anya.. Ọ bụrụ na ederede bụ isi na-ahapụ nkọwa nnu, Ndị na-ekpe ikpe na-aka akara mgbagha ahụ dị ka "TFA akọwapụtaghị / nke a na-echeghị n'echiche" wee mezie akara ntụkwasị obi..

Ebe nyocha ikpe B: Nkwenye QC Orthogonal

Ndị na-ekpe ikpe na-akwado ma a na-akwado ịdị ọcha nke akọwara site na ụzọ orthogonal (eg., LC-MS monoisotopic mass nkwenye gbakwunyere SEC-HPLC maka nchịkọta) ma ọ bụ dabere na otu akara RP-HPLC na-akwadoghị.

Ebe nyocha ikpe C: Nhazi ọdịnaya Peptide net

Ebe a na-akọ oke ibu na-enweghị NPC, Ndị ọkachamara mmadụ na-agbakọ ọdịnaya peptide net nke usoro ihe omume site na iji ụdị ihe mejupụtara amino acid ma ọ bụ chọọ nkwenye CoA mgbakwunye.

Ebe nyocha ikpe D: Ike na Nkwekọ n'Ụgbọgbọ Ndụ

Ndị ọka ikpe na-enyocha ụgbọ ala omenala cell, ihe mejupụtara echekwa, pH, yana njikwa njikọ protein iji gosi na ike ndu akọpụtara na-egosipụta ezi mmekọrịta ebumnuche kama ịbụ nsi ụgbọ ala..

Ubi metadata dị mkpa maka ntụnyere Peptide

Ịmepụta njikọ akaebe nwere ike ịgọnarị maka nchọpụta ọgwụ dị n'ime ma ọ bụ ndenye iwu iwu mpụga, Ọmụmụ ihe ọ bụla akwadoro ga-ejiderịrị atụmatụ metadata ngalaba 8 ahaziri ahazi.

Ngalaba metadata	Mpaghara Schema achọrọ	Nkọwa & Ọkọlọtọ	Mmetụta nke ubi na-efu efu
1. Njirimara nke izizi	`sequence_helm_notation`	Usoro amino acid kpọmkwem site na iji akara HELM ma ọ bụ IUPAC, gụnyere D-amino acid na ihe ndị na-ekwekọghị n'okike.	Nchọpụta ebumnuche na mperi nhazi usoro ezighi ezi.
2. Mgbanwe	`regioselective_modifications`	Mgbanwe ọnọdụ-kpọmkwem (eg., N-terminal acetylation, C-terminal amidation, disulfide àkwà mmiri, PEGylation).	Njikọta nke isomers ọnọdụ nwere profaịlụ ndu dị iche iche.
3. Nnu & Mkpesa	`counterion_species_and_content`	Ụdị nnu pụrụ iche (TFA, Acetate, HCl) na ọnụọgụ ngụkọ ọnụọgụgụ (a tụrụ ya site na IC, GC, ma ọ bụ 19F-NMR).	Enweghị ike ịza ajụjụ maka nsí cell na-akpata mgbagha ma ọ bụ arịa pH.
4. Netwọk ọdịnaya	`net_peptide_content_pct`	Ezi ntakiri uka peptide dị ka pasenti oke ibu ntụ ntụ lyophilized (tụọ ya site na nyocha AAA ma ọ bụ nitrogen).	Dosing ngụkọta oge njehie nke 20% ka 40% gafee meta-nyocha atụnyere.
5. Ịdị ọcha & QC	`orthogonal_purity_metrics`	RP-HPLC pasentị ịdị ọcha kacha elu, ogologo oge nchọpụta (nm), yana ọkwa nkwado LC-MS/SEC-HPLC orthogonal.	Ọdịda achọpụta adịghị ọcha na-amịkọrọ UV ma ọ bụ nchikota soluble.
6. Ọnọdụ anụ ahụ	`aggregation_and_solubility`	Monomeric vs. steeti oligomeric, ụgbọ ala pH, ike nchekwa, na ihe mgbakwunye solubilization (eg., DMSO, Abụọ-80).	Na-eketa enweghị mmekwata nke mkpokọta na-ebute adịghị mma n'usoro adịghị mma.
7. Ụgbọ ala bioassay	`assay_media_and_binding`	Ọdịnaya nke serum, ihe mejupụtara ụgbọ ala, okpomọkụ, oge incubation, na njikwa njide ụgbọ mmiri na-abụghị nke akọwapụtara.	Ọgụgụ IC50/EC50 na-ekwekọghị ekwekọ n'ihi mgbasa nke peptide na plasticware.
8. Nchọgharị	`batch_traceability_coa`	Koodu batch / otutu pụrụ iche, nhazi ọkwa ụlọ dị ọcha, yana ọkwa nkwenye CoA.	Enweghị nyocha n'oge nyocha ngwugwu data IND/NDA.

Atụmatụ nlele iji nyochaa mmepụta AI maka nkwụghachi ụgwọ nchịkwa

Iji gosi na pipeline curation na-enyere AI aka na-emezu ụkpụrụ Cochrane nke iguzosi ike n'ezi ihe., Ndị otu biopharma ga-emejuputa nyocha njikwa njikwa ndekọ ọnụ ọgụgụ. Naanị ịlele ndekọ ndekọ enweghị usoro ezughi oke; nyocha ga-abụrịrị usoro, ize ndụ-stratified, na e dekọkwara ya na mgbakọ na mwepụ.

Maka ndụmọdụ: Mejuputa ụkpụrụ mmịpụta okpukpu abụọ n'oge nrịbama pipeline mbụ. Ịgbakọ metrik nkwekọrịta n'etiti ndị na-eme ihe ngosi dị ka Cohen's Kappa na-eme ka ịwepụta akpaghị aka gị ga-ezute ọnụ ụzọ ziri ezi nke usoro iwu tupu ịmalite..

1. Ihe Nlereanya Nleba anya n'ihe ize ndụ

Kama n'otu n'otu random sample, kewaa ndekọ data ewepụtara gaa n'ụdị ihe egwu dabere na usoro nhazi na mmetụta sayensị nwere ike ime:

Stratum dị ize ndụ (100% Nyocha mmadụ): Ndekọ niile na-akwado ozugbo nhọpụta onye isi na vivo, benchmarks dosing nnwale ụlọ ọgwụ, ma ọ bụ ihe dị mkpa nchekwa/nsi njedebe.
Ọkara-ihe ize ndụ Stratum (20-30% Random nyocha): In vitro SAR na-ejikọta data nyocha, ihuenyo mmekọ dị elu, na nyocha sel nke abụọ.
Stratum dị obere ihe ize ndụ (5-10% Random Nyocha): Akwụkwọ akụkọ ndabere sara mbara, nchịkọta akụkọ ihe mere eme na-amịpụta, yana ọmụmụ ihe nleba anya nke mbido.

2. Atụ Agreement Mwepụta: Cohen's Kappa

Maka mpaghara metadata nkewa (dị ka counterion ụdị, orthogonal QC ọnụnọ, na ụdị mgbanwe), gbakọọ nkwekọrịta inter-annotator n'etiti ụdị AI na ndị ọkachamara ọkachamara mmadụ na-eji Cohen's Kappa (Maazị):

κ = (Pₒ - Pₑ) / (1 - Pₑ)

Ebee:

Pₒ bụ akụkụ nke nkwekọrịta dị n'etiti mmịpụta AI na ikpe ndị ọkachamara mmadụ.
Pₑ bụ oke nkwekọrịta a na-atụ anya ya n'okpuru ohere.

Ebe ezubere iche: Maka ngwungwu akaebe ezubere maka ntinye iwu IND ma ọ bụ NDA, ọkpọkọ ahụ ga-enwerịrị akara Cohen's Kappa n'ozuzu ya k ≥ 0.85 n'ofe ngalaba metadata niile.

3. Oke oke nnabata nke mperi dị egwu

A na-ekewa njehie mmịpụta n'ime ụdị ọrụ ike abụọ dị iche iche:

Njehie dị egwu: Amino acid na-emehie usoro, ịhapụ ọnọdụ mgbanwe, na-ejikọta oke ibu yana ọdịnaya peptide net, ma ọ bụ mgbagwoju anya TFA salts na acetate salts.
- Oke ndidi: < 2.0% Ọnụego mperi dị egwu. Nyocha batch ọ bụla karịrị 2.0% na-ebute nkwụsị ozugbo, ngwa ngwa re-engineering, na 100% akwụkwọ ntuziaka re-ikpe nke stratum.
Obere mperi: Ịmepụta ọdịiche dị n'aha ndị edemede, mpe mpe mpe mpe mpe mpe mpe mpe mpe akwụkwọ n'agụmagụ adịghị mkpa, ma ọ bụ na-efunahụ mkpado ntụaka na-adịghị mkpa.
- Oke ndidi: < 5.0% Ọnụego mperi mperi.

Ịsụgharị Iguzosi Ike n'ezi ihe ka ọ bụrụ eziokwu Ground Ready Lab

Itinye n'ọrụ pipeline ngwọta ihe akaebe Cochrane na-achọ ntọala ndabere ala-eziokwu a pụrụ ịdabere na ya. Mgbe ị na-enyocha mmịpụta AI ma ọ bụ na-ahazi ụdị SAR amụma, Otu nyocha biopharma na-adabere na data nnwale ewepụtara site na njirimara siri ike, Ụkpụrụ peptide edekọtara nke ọma.

Nke a bụ ebe ụkpụrụ nrụpụta pụrụ iche na-adị mkpa. Ụlọ ọrụ nyocha na ndị otu mmepe biotech na-adabere na nyiwe dị ka MOL mgbanwe iji guzobe usoro nyocha na-enweghị nkwekọrịta. Site n'inye ihe zuru oke synthesis peptide omenala na ntụgharị counterion nhọrọ-gụnyere nkwenye nke TFA-to-acetate ma ọ bụ TFA-to-HCl nnu mgbanwe-ndị nchọpụta nwere ike iwepụ ihe ndị na-emegide ihe na isi iyi anụ ahụ..

Ọzọkwa, nhazi usoro nhazi ihe akaebe chọrọ ntụkwasị obi n'ichepụta ọnọdụ ime ụlọ dị ọcha na omimi nyocha. Na-arụ ọrụ n'okpuru otu ISO 9001:2015 na Klas 100 Cleanroom nyocha QC akụrụngwa, Mgbanwe MOL na-ahụ na nza ọ bụla agbakwunyere na-enweta ule siri ike nke ọtụtụ ọkwa. Ma ọ na-eduzi njikarịcha SAR na mgbanwe peptide CRO pụrụ iche gafee 300+ otu na-arụ ọrụ ma ọ bụ na-enyocha nzaba-na-nza site na Nnwale nyocha nke orthogonal peptide na nkwenye CoA (na-ekpuchi ịdị ọcha RP-HPLC, LC-MS monoisotopic mass nkwenye, net peptide ọdịnaya, na ọkwa endotoxin), Inwe nnwale nnwale agbaziri agbaziri na-ahụ na njikwa ihe akaebe dijitalụ gị ka dabere na eziokwu anụ ahụ zuru oke.

Nchịkọta & Ndepụta mmejuputa iwu

Mkpebi Cochrane na AI na njikọ ihe akaebe bụ oku maka nzaghachi sayensị. Site na iji usoro nhazi ngwakọ ejikọtara ọnụ dochie akpaaka AI enyochabeghị, Ndị otu biopharma nwere ike ijikwa arụmọrụ AI na-enweghị ịchụ n'ihu usoro iwu ma ọ bụ iguzosi ike n'ezi ihe sayensị..

Ndepụta ihe omume ozugbo maka ihe akaebe Biopharma:

Nyochaa usoro ọrụ dị ugbu a: Chọpụta ebe LLM na-enwetabeghị akwụkwọ ugbu a na-ewepụta akwụkwọ peptide ma ọ bụ datasets n'ofe nzukọ gị.
Nyefee atụmatụ ngalaba 8: Melite ụlọ nchekwa data iji nye ikike maka ụdị nnu mgbochi, pasent ọdịnaya peptide net, na ọkwa QC orthogonal.
Mepụta ebe nlele ikpe: Mejuputa iwu nlebanya ọkachamara mmadụ maka isi ihe data nwere nnukwu ihe egwu, kpọmkwem gburugburu nnu ụdị, NPC mgbako, na nsị ụgbọala.
Nlele Ogo Statistical Institute: Nyochaa arụmọrụ mmịpụta site na iji nlere anya nke nwere ihe egwu wee manye iwu siri ike <2.0% oke oke mperi mperi (k ≥ 0.85) maka nhazi-eche ihu syntheses.
Arịlịka gaa na ụkpụrụ nnwale egosipụtara: Gbaa mbọ hụ na edobere ụdị dijitalụ niile na usoro ihe akaebe megide njirimara zuru oke, ụkpụrụ nyocha akwadoro.

Bingyan Gao

Ọkachamara na nyocha nyocha Ọkachamara isi: Nkewa na njirimara nke adịghị ọcha, Mmepe usoro HPLC/MS, chiral ịdị ọcha analysis, yana nrube isi na mba ụwa pharmacopoeias.

Profaịlụ: Bingyan Gao bụ "onye nche ọnụ ụzọ ámá" nke ịdị ọcha na ịdị mma peptide. Ọ maara nke ọma n'iji ngwa nyocha dị elu dị iche iche na ọkachamara n'ịzụlite ụzọ nkewa chromatographic ahaziri maka peptides gbanwetụrụ nke ukwuu.. O guzobela usoro profaịlụ adịghị ọcha siri ike nke na-abụghị naanị na-eme ka ngwaahịa dị ọcha nke 99% ma ọ bụ karịa mana ọ na-achọpụtakwa kpọmkwem ma kpochapụ adịghị ọcha nke nwere ike ịkpata immunogenicity. Site na nghota miri emi nke iwu FDA na EMA chọrọ maka ọgwụ peptide, ọ na-ahụ na ogbe ọ bụla ewepụtara na ụlọ ọrụ ahụ na-esonyere ya na Asambodo nyocha zuru oke na ikike. (COA).

Ngwaahịa

Akụkọ